Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias : Results of a multicenter trial

Patients with supraventricular arrhythmias have been safely and effectively treated with flecainide. An open-label, 20-center trial was conducted to define further the safety and efficacy profile of oral flecainide in patients with supraventricular arrhythmias.

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1996-01, Vol.77 (3), p.72A-82A
Main Authors: HOPSON, J. R, BUXTON, A. E, RINKENBERGER, R. L, KOONLAWEE NADEMANEE, HEILMAN, J. M, KIENZLE, M. G
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cardiac arrhythmia
Cardiac dysrhythmias
Cardiology. Vascular system
Clinical trials
Heart
Medical research
Medical sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with supraventricular arrhythmias have been safely and effectively treated with flecainide. An open-label, 20-center trial was conducted to define further the safety and efficacy profile of oral flecainide in patients with supraventricular arrhythmias.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(97)89121-7